Total Funding
23
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
- Richard Christopher: Chief Financial Officer
Thomas R. Ulich: Chief Scientific OfficerPast Role: ConjuChem, Executive Vice-President of Research and Development
About the Company
InVivo Therapeutics Corporation is a medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injuries.
The company was founded in 2005 on the basis of research initiated in Cambridge, Massachusetts, United States.
